Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Ressources
Guidelines | 2023
Youth, Withdrawal, Hospitals, Clinical guidance, About prescribers
Guidelines | 2023
Stimulants, About prescribers, Clinical guidance
Guidelines | 2023
About prescribers, Withdrawal, Clinical guidance
Guidelines | 2023
Clinical guidance, Harm reduction, Safer supply, About prescribers
Guidelines | 2023
Clinical guidance, Harm reduction, Safer supply, About prescribers
The purpose of this guidance is to provide policy recommendations for territorial, provincial and federal takehome naloxone (THN) programs, using evidence from scientific and grey literature and co
Guidelines | 2023
Policy/Regulatory, Harm reduction, Clinical guidance, Overdose
Guide | 2023
à propos des pharmaciens, à propos des prescripteurs, les guides de pratique clinique, la politique / le cadre de réglementation, l'hésitation des prescripteurs, l'approvisionnement plus sécuritaire
Our objective was to provide preventive care recommendations that promote health equity by prioritizing effective interventions for people experiencing disadvantages.
Guidelines | 2023
Equity, Clinical guidance
Guidelines | 2023
Clinical guidance, Substitution/OAT
Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, à propos des pharmaciens, la surdose, la mortalité, la politique / le cadre de réglementation
Guidelines | 2022
Overdose, Clinical guidance
We conducted a policy scan of UDS guidelines, examining the published clinical practice guidelines for each Canadian province and extracting all relevant data in March 2017.
Guidelines | 2018
Clinical guidance, Substitution/OAT, About prescribers
Guide | 2023
les guides de pratique clinique, le traitement de substitution/TAO
Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, le traitement de substitution/TAO
Guidelines | 2023
Clinical guidance, Harm reduction, Safer supply, About prescribers
Guidelines | 2023
Clinical guidance, About prescribers, Substitution/OAT
Guidelines | 2022
Clinical guidance, Safer supply, Policy/Regulatory, About prescribers
Guidelines | 2022
Clinical guidance, About prescribers
